Credit Suisse analyst Jailendra Singh initiated coverage of Tivity Health with a Neutral rating and $22 price target. The analyst believes that the company can benefit from industry tailwinds such as "strong growth" in Medicare Advantage, greater focus on the "social determinants" in healthcare, and higher obesity rates. Singh further cites Tivity's strong brand recognition among seniors for its SilverSneakers fitness program for Medicare and expects the company's Healthcare segment to achieve "at least " a high-single digit revenue growth over the near term.